NantKwest, Inc. (NK): Price and Financial Metrics
NK Price/Volume Stats
| Current price | $32.49 | 52-week high | $45.42 |
| Prev. close | $28.28 | 52-week low | $2.52 |
| Day low | $29.74 | Volume | 1,109,000 |
| Day high | $33.15 | Avg. volume | 1,568,129 |
| 50-day MA | $22.98 | Dividend yield | N/A |
| 200-day MA | $12.74 | Market Cap | 3.55B |
NK Stock Price Chart Interactive Chart >
NantKwest, Inc. (NK) Company Bio
NantKwest is a clinical-stage immunotherapy company focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases. The company was founded in 2002 and is based in Cardiff-by-the-Sea, California.
NK Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NK Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 456.34% |
| YTD | N/A |
| 2024 | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | 251.72% |